This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gozar, M. M. G.
Right arrow Articles by Kaslow, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gozar, M. M. G.
Right arrow Articles by Kaslow, D. C.

 Previous Article  |  Next Article 

Infect. Immun., 01 1998, 59-64, Vol 66, No. 1
Copyright © 1998, American Society for Microbiology

Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice

MM Gozar, VL Price and DC Kaslow
Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425, USA.

Transmission-blocking vaccines based on sexual-stage surface antigens of Plasmodium falciparum may assist in the control of this lethal form of human malaria. Two vaccine candidates, Pfs25 and Pfs28, were produced as single recombinant fusion proteins. The 39-kDa chimeric proteins, having a C-terminal His6 tag, were secreted by Saccharomyces cerevisiae, using the prepro-alpha-factor leader sequence. Pfs25-28 fusion proteins were significantly more potent than either Pfs25 or Pfs28 alone in eliciting antibodies in mice that blocked oocyst development in Anopheles freeborni mosquitoes: complete inhibition of oocyst development in the mosquito midgut was achieved with fewer vaccinations, at a lower dose, and for a longer duration than with either Pfs25 or Pfs28 alone. Increased antigen-specific immunoglobulin G titers and highly significant lymphoproliferative stimulation by Pfs28-containing antigens suggest the presence of an immunodominant helper T-cell epitope in the Pfs28 portion of the fusion proteins. This epitope may be responsible for the enhanced humoral response to both Pfs25 and Pfs28 antigens. Protein production of the fusion protein was improved 12-fold by converting Pfs28 codons to yeast-preferred codons (TBV28), using a modified ADH2 promoter and incorporating a (Glu-Ala)2 repeat after the Kex2 cleavage site.


This article has been cited by other articles:

  • Arakawa, T., Komesu, A., Otsuki, H., Sattabongkot, J., Udomsangpetch, R., Matsumoto, Y., Tsuji, N., Wu, Y., Torii, M., Tsuboi, T. (2005). Nasal Immunization with a Malaria Transmission-Blocking Vaccine Candidate, Pfs25, Induces Complete Protective Immunity in Mice against Field Isolates of Plasmodium falciparum. Infect. Immun. 73: 7375-7380 [Abstract] [Full Text]  
  • AREVALO-HERRERA, M., SOLARTE, Y., YASNOT, M. F., CASTELLANOS, A., RINCON, A., SAUL, A., MU, J., LONG, C., MILLER, L., HERRERA, S. (2005). INDUCTION OF TRANSMISSION-BLOCKING IMMUNITY IN AOTUS MONKEYS BY VACCINATION WITH A PLASMODIUM VIVAX CLINICAL GRADE PVS25 RECOMBINANT PROTEIN. Am J Trop Med Hyg 73: 32-37 [Abstract] [Full Text]  
  • Li, F., Templeton, T. J., Popov, V., Comer, J. E., Tsuboi, T., Torii, M., Vinetz, J. M. (2004). Plasmodium Ookinete-secreted Proteins Secreted through a Common Micronemal Pathway Are Targets of Blocking Malaria Transmission. J. Biol. Chem. 279: 26635-26644 [Abstract] [Full Text]  
  • Coban, C., Ishii, K. J., Stowers, A. W., Keister, D. B., Klinman, D. M., Kumar, N. (2004). Effect of CpG Oligodeoxynucleotides on the Immunogenicity of Pfs25, a Plasmodium falciparum Transmission-Blocking Vaccine Antigen. Infect. Immun. 72: 584-588 [Abstract] [Full Text]  
  • SATTABONGKOT, J., TSUBOI, T., HISAEDA, H., TACHIBANA, M., SUWANABUN, N., RUNGRUANG, T., CAO, Y.-M., STOWERS, A. W., SIRICHAISINTHOP, J., COLEMAN, R. E., TORII, M. (2003). BLOCKING OF TRANSMISSION TO MOSQUITOES BY ANTIBODY TO PLASMODIUM VIVAX MALARIA VACCINE CANDIDATES PVS25 AND PVS28 DESPITE ANTIGENIC POLYMORPHISM IN FIELD ISOLATES. Am J Trop Med Hyg 69: 536-541 [Abstract] [Full Text]  
  • Langer, R. C., Li, F., Vinetz, J. M. (2002). Identification of Novel Plasmodium gallinaceum Zygote- and Ookinete-Expressed Proteins as Targets for Blocking Malaria Transmission. Infect. Immun. 70: 102-106 [Abstract] [Full Text]  
  • Tsai, Y.-L., Hayward, R. E., Langer, R. C., Fidock, D. A., Vinetz, J. M. (2001). Disruption of Plasmodium falciparum Chitinase Markedly Impairs Parasite Invasion of Mosquito Midgut. Infect. Immun. 69: 4048-4054 [Abstract] [Full Text]  
  • Stowers, A. W., Cioce, V., Shimp, R. L., Lawson, M., Hui, G., Muratova, O., Kaslow, D. C., Robinson, R., Long, C. A., Miller, L. H. (2001). Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial. Infect. Immun. 69: 1536-1546 [Abstract] [Full Text]  
  • Langer, R. C., Hayward, R. E., Tsuboi, T., Tachibana, M., Torii, M., Vinetz, J. M. (2000). Micronemal Transport of Plasmodium Ookinete Chitinases to the Electron-Dense Area of the Apical Complex for Extracellular Secretion. Infect. Immun. 68: 6461-6465 [Abstract] [Full Text]  
  • Stowers, A. W., Keister, D. B., Muratova, O., Kaslow, D. C. (2000). A Region of Plasmodium falciparum Antigen Pfs25 That Is the Target of Highly Potent Transmission-Blocking Antibodies. Infect. Immun. 68: 5530-5538 [Abstract] [Full Text]  
  • Vinetz, J. M., Dave, S. K., Specht, C. A., Brameld, K. A., Xu, B., Hayward, R., Fidock, D. A. (1999). The chitinase PfCHT1 from the human malaria parasite Plasmodium falciparum lacks proenzyme and chitin-binding domains and displays unique substrate preferences. Proc. Natl. Acad. Sci. USA 96: 14061-14066 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»